DPP-4 suppression augmented CXCL12/CXCR4 levels, which led to autophagy and HIF-1α in breast cancer cells; a CXCR4 inhibitor reversed these DPP-4 inhibition-induced alterations. Here, CXCL12 is linked to breast cancer.